27.64  1.24 (4.7%)		10-04 16:00
Open: 26.53 High: 27.89 Volume: 22,916		Pre. Close: 26.4 Low: 26.505 Market Cap: 324(M)

Short term
Mid term
Targets	6-month :	34.92	1-year :	40.79
Resists	First :	29.89	Second :	34.92
Pivot price	27.36
Supports	First :	27.07	Second :	25.32
MAs	MA(5) :	27	MA(20) :	27.46
	MA(100) :	26.32	MA(250) :	22.99
MACD	MACD :	-0.3	Signal :	-0.2
%K %D	K(14,3) :	39.6	D(3) :	37.3
RSI	RSI(14): 51.6
52-week	High :	30.36	Low :	14.27

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ XOMA ] has closed below upper band by 44.2%. Bollinger Bands are 1.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	27.92 - 28.03	28.03 - 28.13
Low:	26.21 - 26.34	26.34 - 26.45
Close:	27.4 - 27.63	27.63 - 27.82

XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.

Fri, 04 Oct 2024
Trend Tracker for (XOMA) - Stock Traders Daily

Mon, 23 Sep 2024
XOMA shares hold as analyst reiterates Buy rating post-FDA nod - Investing.com

Mon, 23 Sep 2024
XOMA Royalty Declares Quarterly Preferred Stock Dividends - StockTitan

Mon, 23 Sep 2024
XOMA Royalty Declares Quarterly Preferred Stock Dividends - GlobeNewswire

Wed, 04 Sep 2024
XOMA Royalty to Present at Upcoming Investor Conferences in September - GlobeNewswire

Wed, 14 Aug 2024
XOMA Royalty Second Quarter 2024 Earnings: Beats Expectations - Yahoo Finance

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Outperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares Out	12 (M)
Shares Float	8 (M)
Held by Insiders	0.5 (%)
Held by Institutions	66 (%)
Shares Short	244 (K)
Shares Short P.Month	259 (K)

EPS	-2.21
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	8.56
Profit Margin	-119.7 %
Operating Margin	-9.8 %
Return on Assets (ttm)	-6.7 %
Return on Equity (ttm)	-17.4 %
Qtrly Rev. Growth	568.5 %
Gross Profit (p.s.)	0
Sales Per Share	1.3
EBITDA (p.s.)	-1.64
Qtrly Earnings Growth	0 %
Operating Cash Flow	-8 (M)
Levered Free Cash Flow	-11 (M)

PE Ratio	-12.57
PEG Ratio	-11.2
Price to Book value	3.22
Price to Sales	21.21
Price to Cash Flow	-39.2

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.